drugset / Trial / NCT03833063

Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression

NCT03833063

Phase 1 Withdrawn Helse Stavanger HF
RandomizedCrossoverQuadruple-blindTreatment

Summary

The effectiveness of glabellar injection of botulinum toxin type A (BTA) in treating depression has not yet been investigated in elderly patients. The study aims in addressing the question if glabellar injection of BTA is effective in treating geriatric depression.

Timeline

Start
2019-05-01
Primary completion
2019-12-31
Completion
2020-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic Other